Apolipoprotein E Phenotypes and the Relationship Among Lipid Levels, Nutrient Intakes, Lifestyles and Risk Factors Between Subjects with and without Hyperlipidemic Risk

Apolipoprotein E 다형성과 고지혈증 위험 유무에 따른 혈중 지질농도, 영양소 섭취, 생활습관 및 위험요인과의 관계

  • Lee, Jae-Eun (Graduate School of Education, Chung Ang University) ;
  • Cho, Sang-Woon (Radiation Health Research Institute, Korea Hydro & Nuclear Power Co., Ltd) ;
  • Kang, Ji-Yeon (Radiation Health Research Institute, Korea Hydro & Nuclear Power Co., Ltd) ;
  • Paek, Yun-Mi (Radiation Health Research Institute, Korea Hydro & Nuclear Power Co., Ltd) ;
  • Choi, Chang-Sun (Graduate School of Education, Chung Ang University) ;
  • Park, Yoo-Kyoung (Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Choi, Tae-In (Radiation Health Research Institute, Korea Hydro & Nuclear Power Co., Ltd)
  • 이재은 (중앙대학교 교육대학원) ;
  • 조상운 (한국수력원자력(주) 방사선보건연구원) ;
  • 강지연 (한국수력원자력(주) 방사선보건연구원) ;
  • 백윤미 (한국수력원자력(주) 방사선보건연구원) ;
  • 최창순 (중앙대학교 교육대학원) ;
  • 박유경 (경희대학교 동서의학대학원 의학영양학과) ;
  • 최태인 (한국수력원자력(주) 방사선보건연구원)
  • Published : 2008.07.30

Abstract

This study was performed to investigate Apolipoprotein E phenotypes and the relationship among lipid levels, nutrient intakes, lifestyles and risk factors between subjects with and without hyperlipidemic risk. The data were collected from 675 industrial male workers who had completed annual medical examination. Compared to the normal group, the hyperlipidemic risk group in Apo E3 and E4 had significantly higher BMI (p < 0.05) and showed significantly higher body fat (%), waist circumference and WHR in all types of Apo E (p < 0.05). In addition, the hyperlipidemic risk group had significantly higher total cholesterol, LDL-cholesterol, triglyceride and AI than the normal group in all types of Apo E (p < 0.05). Intakes of protein, calcium, phosphorus, iron, vitamin A, vitamin B1, vitamin B2, vitamin C and niacin in Apo E3 were significantly lower in the hyperlipidemic risk group than in the normal group (p < 0.05). In the logistic regression analysis, after adjustment for other factors, Apo E2 + E4, waist and WHR were the significant risk factors associated with hyperlipidemia, but protein intakes were associated with significantly lower risks of hyperlipidemia (p < 0.05). In conclusion, genetic factor (Apo E2 or Apo E4), anthropometric index and nutrient intake seem to influence hyperlidemic risk. Further studies and efforts will be needed to evaluate the independent relationships among hyperlipidemic risk factors.

Keywords

References

  1. Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990; 31(7): 1149-1172
  2. Lindeberg S, Berntorp E, Nilsson-Ehle P, Terent A, Vessby B. Age relations of cardiovascular risk factors in a traditional Melanesian society: the Kitava Study. Am J Clin Nutr 1997; 66(4): 845-852 https://doi.org/10.1093/ajcn/66.4.845
  3. Kim SJ, Choue RW, Yim JE, Kim YS. Effects of apo E polymorphisms and dietary counseling on the levels of plasma lipids in hyperlipidemic patients. Korean J Nutr 1998; 31(9): 1411-1421
  4. Yin R, Pan S, Wu J, Lin W, Yang D. Apolipoprotein E gene polymorphism and serum lipid levels in the Guangxi Hei YiZhuang and Han populations. Exp Biol Med 2008; 233(4): 409-418 https://doi.org/10.3181/0709-RM-254
  5. Hernandez-Nazara ZH, Ruiz-Madrigal B, Martinez-Lopez E, Roman S, Panduro A. Association of the epsilon 2 allele of APOE gene to hypertriglyceridemia and toearly-onset alcoholic cirrhosis. Alcohol Clin Exp Res 2008; 32(4): 559-566 https://doi.org/10.1111/j.1530-0277.2007.00607.x
  6. Zannis VI, Just PW, Breslow JL. Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet 1981; 33(1): 11-24
  7. Zannis VI, Breslow JL, Utermann G, Mayley RW, Weisgraber KH, Havel RJ, Goldstein JL, Brown MS, Schonfeld G, Hazzard WR, Blum C. Proposed nomenclature of apo E isoproteins, apo E genotypes and phenotypes. J Lipid Res 1982; 23: 911-914
  8. Mahley RW. Apo E cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-630 https://doi.org/10.1126/science.3283935
  9. Han KH, Choe SC, Chae IH, Kim HS, Sohn DW, Oh BH, Lee MM, Park YB, Choi YS, Lee YW. The frequency distribution of Apolipoprotein E genetic polymorphism and relationship of Apolipoprotein E genetic polymorphism with development of coronary artery disease in patients with familial hypercholesterolemia. Korean J Med 1998; 55(6): 1039-1048
  10. Hagberg JM, Wilund KR, Ferrell RE. Apo E gene and gene-enviroment effects on plasma lipoprotein-lipid levels. Physiol Genomics 2000; 4(2): 101-108 https://doi.org/10.1152/physiolgenomics.2000.4.2.101
  11. Fulton JE, Dai S, Grunbaum JA, Boerwinkle E, Labarthe DR. Apolipoprotein E affects serial changes in total and low-density lipoprotein cholesterol in adolescent girls: Project HeartBeat. Metabolism 1999; 48: 285-290 https://doi.org/10.1016/S0026-0495(99)90073-2
  12. Kamboh MI, Aston CE, Ferrell RE, Hamman RF. Impact of apolipoprotein E polymorphism in determining inter-individual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites. Atherosclerosis 1993; 98(2): 201-211 https://doi.org/10.1016/0021-9150(93)90129-I
  13. Xu CF, Boerwinkle E, Tikkanen MJ, Huttunen JK, Humphhries SE, Talmud PJ. Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change. Genetic Epidemiol 1990; 7(4): 261-275 https://doi.org/10.1002/gepi.1370070405
  14. Simopolulos P. Genetic variation and nutrition. Biomed Enviromental Science 1996; 9: 124-129
  15. Honda K, Murase T. Effects apolipoprotein E phenotype on serum cholesterol level and cholesterol response to diet theraphy in patients with hypercholesterolemia. Endocr J 1997; 44(3): 425-429 https://doi.org/10.1507/endocrj.44.425
  16. Zambon D, Emilio R, Elena C, Carolina S, Antonia B, Isabel C. Effect of apolipoprotein E polymorphism on the serum lipid response to hypolipidemic diet rich in monounsaturated fatty acids in patients with hypercholestrolemia and combind hyperlipidemia. Am J Clin Nutr 1995; 61: 141-148 https://doi.org/10.1093/ajcn/61.1.141
  17. Manttari M, Koskinen P, Ehnholm C, Huttunen JK, Manninen V. Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 1991; 40(2): 217- 221 https://doi.org/10.1016/0026-0495(91)90179-Z
  18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). JAMA 2001; 285(19): 2486-2497 https://doi.org/10.1001/jama.285.19.2486
  19. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31(3): 545-548
  20. WHO. The problem of overweight and obesity. obesity: preventing and managing the global epidemic. Report of a WHO Consultation. WHO publication; 2000. p.5-37
  21. Lee SY, Park HS, Kim SM, Kwon HS, Kim DY, Kim DJ, Cho GJ, Han JH, Kim SR, Park CY, Oh SJ, Lee CB, Kim KS, Ou SW, Kim YS, Choi WH, Yoo HJ. Cut-off points of waist circumference for defining abdominal obesity in the Korean population. J Korean Soc Study Obes 2006; 15(1): 1-9
  22. Leonhardt N, Silbermann A, Silbermann H. Body mass index and waist-to hip ratio in patients of a stomatologic ambulance. Diabetes Res Clin Pract 1990;10 Suppl 1: S129-132 https://doi.org/10.1016/0168-8227(90)90151-I
  23. Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 2004; 141(2): 137-147 https://doi.org/10.7326/0003-4819-141-2-200407200-00013
  24. Bennet AM, Di Angelantonio E, Ye Z, Wensley F, Dahlin A, Ahlbom A, Keavney B, Collins R, Wiman B, de Faire U, Danesh J. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007; 298(11): 1300-131 https://doi.org/10.1001/jama.298.11.1300
  25. Assmann G, Schmitz G, Menzel HJ, Schulte H. Apolipoprotein E polymorphism and hyperlipidemia. Clin Chem 1984; 30(5): 641- 643
  26. Utermann G, Kindermann I, Kaffarnik H, Steinmetz A. Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet 1984; 65 (3): 232-236 https://doi.org/10.1007/BF00286508
  27. Kang SY, Woo JT, Kim SW, Yang IM, Kim JW, Kim YS, Kim KW. Apolipoprotein E genotypes in patients with diabetes, cerebrovascular accident, and acute myocardial infarction. J Korean Soc Endocrinol 1992; 7(3): 273-279
  28. Yim JE, Choun YW, Kim YS, Oh SJ, Paeng JR. Dietary and simvastatin treatment on the blood lipid levels in the patients with hyperlipidemia according to genetic and biochemical markers. Korean J Lipidol 2000; 10(2): 215-229
  29. Choi MJ. Relations of Life Style, Nutrient Intake, and Blood Lipids in Middle-Aged Men with Borderline Hyperlipidemia. Korean J Community Nutrition 2005; 10(3): 281-289
  30. Jemma R, Elasmi M, Naouali C, Feki M, Kallel A, Souissi M, Sanhaji H, Hadj Taieb S, Souheil O, Kaabachi N. Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters. Clin Biochem 2006; 39(8): 816-820 https://doi.org/10.1016/j.clinbiochem.2006.04.018
  31. Shin MH, Kim HN, Cui LH, Kweon SS, Park KS, Heo H, Nam HS, Jeong SK, Chung EK, Choi JS. The effect of apolipoprotein E polymorphism on lipid levels in Korean adults. J Korean Med Sci 2005; 20(3): 361-366 https://doi.org/10.3346/jkms.2005.20.3.361
  32. Park SM, Yu JG. Relationship among apolipoprotein E phenotypes, dietary fat, serum lipoprotein concentrations and erythrocyte membrane fatty acid composition in young healthy women. Korean J Nutr 1997; 30(8): 936-951
  33. Kataoka S, Robbins DC, Cowan LD, Go O, Yeh JL, Devereux RB, Fabsitz RR, Lee ET, Welty TK, Howard BV. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study. Arterioscler Thromb Vasc Biol 1996; 16(8): 918-925 https://doi.org/10.1161/01.ATV.16.8.918
  34. Dietary Reference Intakes For Koreans. The Korean Nutrition Society. Seoul; 2005
  35. Han JH, Park SH. The effects of uncooked food on nutrient intake, body fat and serum lipid compositions in hyperlipidemic patients. Korean J Nutr 2003; 36(6): 589-602
  36. Ornish D, Magbanua MJ, Weidner G, Weinberg V, Kemp C, Green C, Mattie MD, Marlin R, Simko J, Shinohara K, Haqq CM, Carroll PR. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci USA 2008; 105(24): 8369-8374
  37. Djousse L, Myers RH, Province MA, Hunt SC, Eckfeldt JH, Evans G, Peacock JM, Ellison RC. Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke 2002; 33(5): 1357-1361 https://doi.org/10.1161/01.STR.0000014325.54063.1A
  38. Stamford BA, Matter S, Fell RD, Sady S, Papanek P, Cresanta M. Cigarette smoking, exercise and high density lipoprotein cholesterol. Atherosclerosis 1984; 52: 73-84 https://doi.org/10.1016/0021-9150(84)90157-6
  39. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989; 298: 784-788 https://doi.org/10.1136/bmj.298.6676.784
  40. Muscat JE, Hariis RT, Haley NJ, Wynder EL. Cigarette smoking and plasma cholesterol. Am Heart J 1991; 121: 141-147 https://doi.org/10.1016/0002-8703(91)90967-M
  41. Lee KS, Park CY, Meng KH, Bush A, Lee SH, Lee WC, Koo JW, Choung CK. The association of cigarette smoking and alcohol consumption with other cardiovascular risk factors in men from Seoul, Korea. Ann Epidemiol 1998; 8: 31-38 https://doi.org/10.1016/S1047-2797(97)00113-0
  42. Kim BS, Kang JH, Choi K, Jung HW, Lee HS, Lee SJ, Lee MH, Park JR. Relationships between Cigarette Smoking and Serum Lipids in the Normal Population. Korean J Lipidol 1998; 8(2): 120-126
  43. Yim KS. Changes of plasma cardiovascular disease risk factors according to the health practice and dietary habits in health male university students. Korean J Community Nutrition 1998; 3(5): 685-669
  44. Lim HS, Baik IK, Lee HS, Lee YJ, Chung NS, Jho SY, Kim SS. Effect of the life style in patients with coronary artery disease on the serum lipid concentrations and atherosclerotic coronary lesion. Korean J Lipidol 1995; 5(1): 71-83
  45. Lee JH, Cho BM, Lee SI, Kim DK. A study of the relationship between alcohol intake, smoking, relative weight and serum lipids level in young adult male workers. Korean J Prev Med 1992; 25(4): 386-398
  46. Kwak CS, Lee JW, Hyun WJ. The effects of smoking and alcohol drinking on nutritional status and eating habits in adult males. Korean J Community Nutrition 2000; 5(2): 161-171
  47. Marty B, Knobloch M, Riesen WF. Fifteen year changes in exercise, aerobic power, abdominal fat, and serum lipids in runners and controls. Medcine Science Sports Exercise 1991; 23: 115-122
  48. Amond J, Prud'homme D, Moorjani S, Nadeau A, Tremblay A, Bouchard C, Lupien PJ, Despres JP. Apo E polymorphism and the relationships of physical fitness to plasma lipoprotein lipid levels in men and women. Medcine Science Sports Exercise 1999; 31: 692-697 https://doi.org/10.1097/00005768-199905000-00011
  49. Taimela S, Lehtimaki T, Porkka K, Rasanen L, Viikary J. The effect of physical activity on serum total and low-density lipoprotein cholesterol concentration varies with apolipoprotein E phenotype in male children and young adults: the cardiovascular risk in young Finns study. Metabolism 1996; 45: 797-803 https://doi.org/10.1016/S0026-0495(96)90149-3
  50. Hagberg JM, Ferrell RE, Katzel LI, Dengel DR, Sorkin JD, Goldberg AP. Apolipoprotein E genotype and exercise traininginduced increases in plasma high-density lipoprotein (HDL)- and HDL2-cholesterol levels in overweight men. Metabolism 1999; 48(8): 943-945 https://doi.org/10.1016/S0026-0495(99)90185-3
  51. Kim MK. Serum lipids by gender, age and lifestyle in Korean adults. Korean J Community Nutrition 2000; 5(1): 109-119
  52. Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 2005; 81 (2): 397-408 https://doi.org/10.1093/ajcn.81.2.397